| 查看: 849 | 回复: 5 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
wqssfj1铁杆木虫 (著名写手)
|
[求助]
求助翻译
|
||
|
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 分析句子成份加翻译，谢谢！ |
回复此楼» 收录本帖的淘帖专辑推荐
 精品翻译集锦 |
» 猜你喜欢
招博士
已经有6人回复
-
限项规定
已经有8人回复
-
国家基金申请书模板内插入图片不可调整大小?
已经有5人回复
-
交叉科学部支持青年基金，对三无青椒是个机会吗？
已经有3人回复
-
国家级人才课题组招收2026年入学博士
已经有5人回复
-
Fe3O4@SiO2合成
已经有6人回复
-
青年基金C终止
已经有4人回复
-
青椒八年已不青，大家都被折磨成啥样了？
已经有7人回复
-
为什么nbs上溴 没有产物点出现呢
已经有10人回复
-
救命帖
已经有11人回复
17953216334
银虫 (小有名气)
- 翻译EPI: 1
- 应助: 5 (幼儿园)
- 金币: 1241.8
- 红花: 3
- 帖子: 130
- 在线: 116.5小时
- 虫号: 1787064
- 注册: 2012-04-30
- 专业: 高分子助剂
4楼2012-06-25 13:24:01
qin20010
木虫 (小有名气)
小木虫博士生导师
- 应助: 0 (幼儿园)
- 金币: 2012.8
- 帖子: 275
- 在线: 27.4小时
- 虫号: 346589
- 注册: 2007-04-15
- 性别: GG
- 专业: 催化化学
2楼2012-06-25 10:59:20
wqssfj1
铁杆木虫 (著名写手)
- 翻译EPI: 1
- 应助: 2 (幼儿园)
- 金币: 5947.4
- 散金: 21
- 红花: 3
- 帖子: 1448
- 在线: 252.5小时
- 虫号: 1391164
- 注册: 2011-09-05
- 专业: 药物资源
3楼2012-06-25 13:15:47
readbycandle
木虫 (著名写手)
A thinking worm
- 翻译EPI: 55
- 应助: 22 (小学生)
- 贵宾: 0.2
- 金币: 7100.6
- 红花: 13
- 帖子: 2158
- 在线: 460.5小时
- 虫号: 1793835
- 注册: 2012-05-03
- 专业: 美国文学
【答案】应助回帖
|
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 这是两个并列的句子。an evaluationketed....was performed and “Localized exfoliation or blisters” were added . 翻译： However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed 不过，已对自投放市场以来至2012年2月29日诺华公司收到的关于使用vildagliptin (包括Galvus and Eucreas)引起的皮肤反应的所有报告进行了评估， and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 并将“可以引起局部脱皮或水泡”作为市场反馈信息加入目前CDS的副作用说明中。 |
5楼2012-06-28 17:36:35